Antibody Expression in Mammalian Cells

Therapeutic Monoclonal Antibodies: From Bench to Clinic

Volumn , Issue , 2009, Pages 555-572

  Wang, Fubao ^a   Chen, Lorenzo ^a   Connors, Neal ^a   Mach, Henryk ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Analytical and biophysical characterization of purified antibodies; Mammalian cell antibody expression; Transiently expressed antibody purification

Indexed keywords

EID: 84891037018     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470485408.ch25     Document Type: Chapter

References (51)

1. Arakawa, T., J.S. Philo, D. Ejima, K. Tsumoto, and F. Arisaka. 2006. Aggregation analysis of therapeutic proteins. Part 1. BioProcess Int. 4:42-43.
2. Baldi, L., N. Muller, S. Picasso, R. Jacquet, P. Girard, H.P. Thanh, E. Derow, and F.M. Wurm. 2005. Transient gene expression in suspension HEK-293 cells: Application to large-scale protein production. Biotechnol. Progress 21:148-153.
3. Belting, M., and P. Peterson. 1999. Intracellular accumulation of secreted proteoglycans inhibits cationic lipid-mediated gene transfer: Co-transfer of glycosaminoglycans to the nucleus. J. Biol. Chem. 274:19375-19382.
4. Blasey, H.D., J.P. Aubry, G.J. Mazzei, and A.R. Bernard. 1996. Large-scale transient expression with COS cells. Cytotechnology 18:138-142.
5. Boussif, O., F. Lezoualch, M.A. Zanta, M.D. Mergny, D. Scherman, B. Demenex, and J.P. Behr. 1995. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: Polyethylenimine. Proc. Nat. Acad. Sci. U.S.A. 92:7297-7301.
6. Bradford, M.M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248-254.
7. Cachianes, G., C. Ho, R.F. Weber, S.R. Williams, D.V. Goeddel, and D.W. Leung. 1993. Epstein-Barr virus-derived vectors for transient and stable expression of recombinant proteins. Bio/Techniques 15:255-259.
8. Chen, B. et al. 1994. Strategies to suppress aggregation of recombinant keratinocyte growth factor during liquid formulation development. J. Pharm. Sci. 83:1657-1661.
9. w. J. Biomol. Screening 11:854-863.
10. Derouazi, M., P. Girard, F.V. Tilborgh, et al. 2004. Serum-free large-scale transient transfection of CHO cells. Biotechnol. Bioeng. 87:537-545.
11. Durocher, Y., S. Perret, and A. Kamen. 2002. High-level and high throughput recombinant protein production by transient transfection of suspension-growing human 293-EBNA1 cells. Nucleic Acids Res. 30:E9.
12. Epps, D.E., R.W. Sarver, and J.M. Rogers. 2001. The ligand affinity of proteins measured by isothermal denatura-tion kinetics. Anal. Biochem. 292:40-50.
13. European Pharmacopeia. 2002. Particulate Contamination: Subvisible Particles, 2915-2918.
14. Galbraith, D.J., A.S. Tait, A.J. Racher, J.R. Birch, and D.C. James. 2006. Control of culture environment for improved polyethylenimine-mediated transient production of recombinant monoclonal antibodies by CHO cells. Biotechnol. Progress 22:753-762.
15. Ghazal, P., H. Lubon, and L. Hennighausen. 1988a. Specific interactions between transcription factors and the promoter-regulatory region of the human cytomegalovirus major immediate-early gene. J. Virol. 62:1076-1079.
16. Ghazal, P., H. Lubon, and L. Hennighausen. 1988b. Multiple sequence-specific transcription factors modulate cytomegalovirus enhancer activity in vitro. Mol. Cell. Biol. 8:1809-1811.
17. Gill, S.C., and P.H. von Hippel. 1989. Calculation of protein extinction coefficients from amino acid sequence data. Anal. Biochem. 182:319-326.
18. Godbey, W.T., K.K. Wu, and A.G. Mikos. 1999. Poly(ethylenimine) and its role in gene delivery. J. Controlled Release 60:149-160.
19. Graham, F.L., J. Smiley, W.C. Russell, and R. Nairn. 1977. Characteristics of ahuman cell line transformed by DNA from a human adenovirus type 5. J. Gen. Virol. 36:59-74.
20. Haack, A., C. Schmitt, W. Poller, J. Oldenburg, P. Hanfland, H.H. Brackmann, and R. Schwaab. 1999. Analysis of expression kinetics and activity of a new B-domain truncated and full-length FVIII protein in three different cell lines. Ann. Hematol. 78:111-116.
21. Haldankar, R., D. Li, Z. Saremi, C. Baikalov, and R. Deshpande. 2006. Serum-free suspension large-scale transient transfection of CHO cells in WAVE bioreactors. Mol. Biotechnol. 34:191-199.
22. Harn, N., C. Allan, C. Oliver, and C.R. Middaugh. 2007. Highly concentrated monoclonal antibody solutions: Direct analysis of physical structure and thermal stability. J. Pharm. Sci. 96:532-546.
23. Hjerten, S., and K.O. Eriksson. 1984. High-performance molecular sieve chromatography of protein on agarose columns: The relations between concentration and porosity of the gel. Anal. Biochem. 137:313-317.
24. Hjerten, S., and R. Mosbach. 1962. "Molecular-sieve" chromatography of proteins on columns of cross-linked poly-acrylamide. Anal. Biochem. 3:109-118.
25. Jordan, M., A. Schallhorn, and F.M. Wurm. 1996. Transfecting mammalian cells: Optimization of critical parameters affecting calcium-phosphate precipitate formation. Nucleic Acids Res. 24:596-601.
26. Kim, C.H., Y. Oh, and T.H. Lee. 1997. Codon optimization for high-level expression of human erythropoietin (EPO) in mammalian cells: Human or yeast codon usage effect on over-expression in 293T cell culture. Gene 199:293-301.
27. Koppel, D.E. 1972. Analysis of macromolecular polydispersity in intensity correlation spectroscopy: The method of cumulants. J. Chem. Phys. 37:4814-4820.
28. Laemmli, U.K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
29. Lindner, S.E., and B. Sugden. 2007. The plasmid replicon of Epstein-Barr virus: Mechanistic insights into efficient, licensed, extrachromosomal replication in human cells. Plasmid 58:1-12.
30. Liu, H., G. Gaza-Bulseco, D. Faldu, C. Chumsae, and J. Sun. 2008. Heterogeneity of monoclonal antibodies. J. Pharm. Sci. 97:2426-2447.
31. Lowry, O.H., N.J. Rosenbrough, A.L. Farr, and R.J. Randall. 1953. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193:265-275.
32. Mach, H., C.R. Middaugh, and R.V. Lewis. 1992. Statistical determination of the average values of the extinction coefficients of tryptophan and tyrosine in native proteins. Anal. Biochem. 200:74-80.
33. Mach, H., G. Sanyal, D.B. Volkin, and C.R. Middaugh. 1997. Applications of ultraviolet absorption spectroscopy to the analysis of biopharmaceuticals. In Therapeutic Protein and Peptide Formulation and Delivery, ed. Z. Shahrokh et al. ACS Symposium Series. Washington, D.C.: American Chemical Society.
34. Mach, H., J.A. Thomson, and C.R. Middaugh. 1989. Quantitative analysis of protein mixtures by second derivative absorption spectroscopy. Anal. Biochem. 181:79-85.
35. Magalhaes, P.O., A.M. Lopes, P.G. Mazzola, C. Rangel-Yagui, T.C.V. Penna, and A. Pessoa. 2007. Methods of endotoxin removal from biological preparations: A review. J. Pharmacy Pharm. Sci. 14:388-404.
36. Muller, N., M. Derouazi, F. Van Tilborgh, S. Wulhfard, D.L. Hacker, M. Jordan, and F.M. Wurm. 2007. Scaleable transient gene expression in Chinese hamster ovary cells in instrumented and non-instrumented cultivation systems. Biotechnol. Lett. 29:703-711.
37. Pace, C.N., F. Vajdos, L. Fee, G. Grimsley, and T. Gray. 1995. How to measure and predict the molar absorption coefficient of a protein. Protein Sci. 4:2411-2423.
38. Pham, P.L., S. Perret, H.C. Doan, B. Cass, G. St.-Laurent, A. Kamen, and Y. Durocher. 2003. Large-scale transient transfection of serum-free suspension-growing HEK-293 EBNA1 cells: Peptone additives improve cell growth and transfection efficiency. Biotechnol. Bioeng. 84:332-342.
39. Phillies, G.D.J. 1990. Quasielastic light scattering. Anal. Chem. 62:1049-1057.
40. Riley, S. 2006. The future of the monoclonal antibody therapeutics: Innovation in antibody engineering, key growth strategies and forecasts to 2011. Business Insights. http://www.globalbusinessinsights.com.
41. Rogers, M.J., and J. Cohen. 1986. Comparison of the binding of gram-negative bacterial endotoxin by polymyxin B sulphate, colistin sulphate and colistin sulphomethate sodium. Infection 14:79-81.
42. Schlatter, S., S.H. Stansfield, D.M. Dinnis, A.J. Racher, J.R. Birch, and D.C. James. 2005. On the optimal ratio of heavy to light chain genes for efficient recombinant antibody production by CHO cells. Biotechnol. Progress 21:122-138.
43. Sieber, V., A. Pluckthun, and F.X. Schmid. 1998. Selecting proteins with improved stability by a phage-based method. Nature Biotechnol. 16:955-960.
44. Tait, A.S., C.J. Brown, D.J. Galbraith, M.J. Hines, M. Hoare, J.R. Birch, and D.C. James. 2004. Transient production of recombinant proteins by Chinese hamster ovary cells using polyethyleneimine/DNA complexes in combination with microtubule disrupting anti-mitotic agents. Biotechnol. Bioeng. 88:707-721.
45. Thomas, P., and T.G. Smart. 2005. HEK293 cell line: A vehicle for the expression of recombinant proteins. J. Pharmacol. Toxicol. Methods 51:187-200.
46. U.S. Pharmacopeia. 2003. Particulate Matter in Injections, 2189-2196.
47. Van den Nieuwenhof, I.M., H. Koistinen, R.L. Easton, R. Koistinen, M. Kamarainen, H.R. Morris, I. van Die, M. Seppala, A. Dell, and D.H. Van den Eijnden. 2000. Recombinant glycodelin carrying the same type of glycan structures as contraceptive glycodelin-A can be produced in human kidney 293 cells but not in Chinese hamster ovary cells. Eur. J. Biochem. 267:4753-4762.
48. Van Holde, K.E. 1985. In Physical Biochemistry, 209-227. Englewood Cliffs, NJ: Prentice-Hall.
49. Wehr, T., and R. Rodriguez-Diaz. 2005. Use of size exclusion chromatography in biopharmaceutical development. In Analytical Techniques for Biopharmaceutical Development, 1st edition, ed. R. Rodriguez-Diaz, T. Wehr, and S. Tuck, 95-112. New York: Marcel Dekker.
50. Wetlaufer, D.B. 1954. Ultraviolet spectra of proteins and amino acids. Adv. Protein Chem. 17:303-390.
51. Wurm, F.M., and A. Bernard. 1999. Large-scale transient expression in mammalian cells for recombinant protein production. Curr. Opin. Biotechnol. 313:156-159.